{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:13:57Z","timestamp":1786407237596,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.exer.2025.110709","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:11:18Z","timestamp":1761300678000},"page":"110709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells"],"prefix":"10.1016","volume":"262","author":[{"given":"Sarah Adriana","family":"Scuderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paterniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110709_bib1","article-title":"L-ergothioneine reduces nitration of lactoferrin and loss of antibacterial activity associated with nitrosative stress","volume":"34","author":"Alhalwani","year":"2023","journal-title":"Biochem Biophys Rep"},{"issue":"4","key":"10.1016\/j.exer.2025.110709_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/bjophthalmol-2019-315747","article-title":"Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review","volume":"105","author":"Aragona","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110709_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102967","article-title":"Oxidative stress in the eye and its role in the pathophysiology of ocular diseases","volume":"68","author":"Bohm","year":"2023","journal-title":"Redox Biol."},{"issue":"23","key":"10.1016\/j.exer.2025.110709_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233936","article-title":"Casein kinase 2 inhibitor, CX-4945, induces apoptosis and restores blood-brain barrier homeostasis in in vitro and in vivo models of glioblastoma","volume":"16","author":"Bova","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.exer.2025.110709_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246244","article-title":"EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth","volume":"16","author":"Bownes","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.exer.2025.110709_bib6","article-title":"Potential new target for dry eye disease-oxidative stress","volume":"13","author":"Bu","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.exer.2025.110709_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030352","article-title":"Beneficial effect of tempol, a membrane-permeable radical scavenger, on inflammation and osteoarthritis in in vitro models","volume":"11","author":"Calabrese","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.exer.2025.110709_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081102","article-title":"EZH2 inhibition to counteract oral cancer progression through wnt\/beta-Catenin pathway modulation","volume":"17","author":"Campolo","year":"2024","journal-title":"Pharmaceuticals (Basel)."},{"issue":"4","key":"10.1016\/j.exer.2025.110709_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/path.5094","article-title":"Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target","volume":"245","author":"Cao","year":"2018","journal-title":"J. Pathol."},{"issue":"14","key":"10.1016\/j.exer.2025.110709_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143593","article-title":"State of the art of pharmacological activators of p53 in ocular malignancies","volume":"15","author":"Casciano","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"44","key":"10.1016\/j.exer.2025.110709_bib11","doi-asserted-by":"crossref","first-page":"76423","DOI":"10.18632\/oncotarget.19462","article-title":"Expression of EZH2 in uveal melanomas patients and associations with prognosis","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.exer.2025.110709_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41385-022-00551-6","article-title":"Mucosal immunology of the ocular surface","volume":"15","author":"de Paiva","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.exer.2025.110709_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126561","article-title":"Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells","volume":"10","author":"Deng","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.exer.2025.110709_bib14","doi-asserted-by":"crossref","first-page":"DES163","DOI":"10.1167\/iovs.17-23402","article-title":"Potential role of oxidative stress in ocular surface inflammation and dry eye disease","volume":"59","author":"Dogru","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.exer.2025.110709_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101539","article-title":"Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population","volume":"45","author":"Garcia-Marques","year":"2022","journal-title":"Contact Lens Anterior Eye"},{"issue":"12","key":"10.1016\/j.exer.2025.110709_bib16","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1167\/iovs.12-11515","article-title":"Neutralization of ocular surface TNF-alpha reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye","volume":"54","author":"Ji","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.exer.2025.110709_bib17","article-title":"Olive pomace phenolic compounds and extracts can inhibit Inflammatory- and oxidative-related diseases of human ocular surface epithelium","volume":"10","author":"Katsinas","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.exer.2025.110709_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","article-title":"Nuclear Factor-kappaB: central regulator in ocular surface inflammation and diseases","volume":"10","author":"Lan","year":"2012","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.exer.2025.110709_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1167\/iovs.16-20634","article-title":"Anti-inflammatory and antioxidative effects of Camellia japonica on human corneal epithelial cells and experimental dry eye: in vivo and in vitro study","volume":"58","author":"Lee","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110709_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jtos.2024.11.004","article-title":"Cell death pathways in dry eye disease: insights into ocular surface inflammation","volume":"34","author":"Li","year":"2024","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2025.110709_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108611","article-title":"Inhibition of enhancer of zeste homolog 2 prevents corneal myofibroblast transformation in vitro","volume":"208","author":"Liao","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1159\/000531530","article-title":"EZH2 expression in retinoblastoma: a potential therapeutic target","volume":"66","author":"Lin","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2025.110709_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2025.110709_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/ICO.0b013e318030d259","article-title":"Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways","volume":"26","author":"Luo","year":"2007","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.exer.2025.110709_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","article-title":"The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases","volume":"13","author":"Mantelli","year":"2013","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.exer.2025.110709_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108944","article-title":"Pathophysiology of dry eye disease and novel therapeutic targets","volume":"217","author":"Messmer","year":"2022","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.exer.2025.110709_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"issue":"15","key":"10.1016\/j.exer.2025.110709_bib28","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.7150\/ijbs.102551","article-title":"Annexin-V binds subpopulation of immune cells altering its interpretation as an in vivo biomarker for apoptosis in the retina","volume":"20","author":"Miyagishima","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.exer.2025.110709_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1173683","article-title":"The environment and dry eye-manifestations, mechanisms, and more","volume":"5","author":"Patel","year":"2023","journal-title":"Front Toxicol"},{"issue":"9","key":"10.1016\/j.exer.2025.110709_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/epi-2023-0147","article-title":"The role of EZH2 in ocular diseases: a narrative review","volume":"15","author":"Peng","year":"2023","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93150-7","article-title":"Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties","volume":"11","author":"Samarkanova","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010731","article-title":"The potential role of regulated cell death in dry eye diseases and ocular surface dysfunction","volume":"24","author":"Scarpellini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.exer.2025.110709_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213915","article-title":"GSK343, an inhibitor of enhancer of zeste homolog 2, reduces glioblastoma progression through inflammatory process modulation: focus on canonical and non-canonical NF-kappaB\/IkappaBalpha pathways","volume":"23","author":"Scuderi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NFkappaB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110709_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020187","article-title":"Role of oxidative stress in ocular diseases: a balancing act","volume":"13","author":"Shu","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.exer.2025.110709_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mito.2017.05.009","article-title":"Mitochondrial dysfunction and oxidative stress in corneal disease","volume":"36","author":"Vallabh","year":"2017","journal-title":"Mitochondrion"},{"issue":"12","key":"10.1016\/j.exer.2025.110709_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/iovs.66.1.24","article-title":"Caspase 3\/GSDME-Mediated corneal epithelial pyroptosis promotes dry eye disease","volume":"66","author":"Wang","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2025.110709_bib39","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1167\/iovs.18-24057","article-title":"Oxidative stress suppresses cellular autophagy in corneal epithelium","volume":"59","author":"Yin","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.exer.2025.110709_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41419-018-0349-8","article-title":"DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.exer.2025.110709_bib41","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41467-019-10176-2","article-title":"Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525004828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:43:41Z","timestamp":1781253821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525004828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0014483525004828"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110709","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110709"}}